ClinVar makes variant interpretations and their supporting information accessible across laboratories and other submitters. Its transparency is a major strength: disagreement becomes visible rather than remaining hidden within separate reports. The aggregate label is a starting point for review, not a substitute for examining what each contributor actually asserted.
Read review status correctly
NCBI’s review-status documentation explains how transparency, agreement and expert review influence the stars displayed on records. An expert-panel submission or practice guideline has a different status from multiple ordinary submissions that agree. The stars describe review status; they are not a numerical probability that a variant is pathogenic or a measure of disease severity. Read the review-status documentation.
A variant with conflicting assertions deserves a structured comparison. Check the condition, inheritance context, assessment date and evidence supplied. Different conclusions may reflect new evidence, different interpretation rules or genuinely unresolved biological questions. A count of submitters cannot determine which explanation applies.
Separate curation from archive processing
NCBI explains that ClinVar validates aspects of submissions but does not independently judge whether each submitter’s classification criteria are appropriate. That distinction is crucial for automated pipelines. Successful inclusion in the archive does not mean the underlying interpretation has been endorsed by NCBI. Read how ClinVar validates submissions.
For a consequential interpretation, return to the actual evidence. An older submission may omit information now available, while a newer one may provide little detail. Resolve whether the same variant, transcript and disease relationship are being compared before deciding that two assertions truly conflict.
Make disagreement actionable
- Record the accession and version used in the analysis.
- Compare dates of evaluation rather than relying only on the page’s update date.
- Identify which evidence would explain or resolve the disagreement.
- Preserve the rationale for accepting one interpretation over another.
For research, discordance can highlight a useful target for additional family or functional evidence. For clinical use, unresolved conflict should remain visible to the responsible laboratory and clinicians. Automated systems can flag changes and prioritize review, but should not silently turn a majority opinion into a definitive diagnosis. The most useful outcome is a documented explanation of the disagreement and its consequences for the specific analysis.